Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: A meta-analysis

Neuroscience Letters

Volumn 523, Issue 2, 2012, Pages 174-179

  Pi, Yan ^a   Zhang, Lili ^a   Chang, Kai ^a   Li, Binghu ^a   Guo, Lu ^a   Fang, Chuanqin ^a   Gao, Changyue ^a   Wang, Jingzhou ^a   Xiang, Jing ^a   Li, Jingcheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Meta analysis; Paraoxonase 1 gene; Polymorphism

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

AFRICAN AMERICAN; ALZHEIMER DISEASE; ARTICLE; ASIAN; CAUCASIAN; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC;

EID: 84864303866     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.071     Document Type: Article

References (34)

1. Bai Y.F., Quan W.X. The association of polymorphism of PON gene in sporadic Alzheimer's disease. Nervous Diseases and Mental Health 2008, 8:420-423.
2. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
3. Brophy V.H., Jampsa R.L., Clendenning J.B., McKinstry L.A., Jarvik G.P., Furlong C.E. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. American Journal of Human Genetics 2001, 68:1428-1436.
4. Cellini E., Tedde A., Bagnoli S., Nacmias B., Piacentini S., Bessi V., Bracco L., Sorbi S. Association analysis of the paraoxonase-1 gene with Alzheimer's disease. Neuroscience Letters 2006, 408:199-202.
5. Chapuis J., Boscher M., Bensemain F., Cottel D., Amouyel P., Lambert J.C. Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease. Neurobiology of Aging 2009, 30:152-156.
6. Dantoine T.F., Drouet M., Debord J., Merle L., Cogne M., Charmes J.P. Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. Annals of the New York Academy of Sciences 2002, 977:239-244.
7. Deakin S., Leviev I., Brulhart-Meynet M.C., James R.W. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position-107, implicating the Sp1 transcription factor. Biochemical Journal 2003, 372:643-649.
8. DerSimonian R., Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemporary Clinical Trials 2007, 28:105-114.
9. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188.
10. Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. Current Opinion in Lipidology 2001, 12:105-112.
11. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurology 2007, 6:734-746.
12. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
13. Erlich P.M., Lunetta K.L., Cupples L.A., Abraham C.R., Green R.C., Baldwin C.T., Farrer L.A. Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease. Neurobiology of Aging 2012, 33. 105.e7-1015.e23.
14. Erlich P.M., Lunetta K.L., Cupples L.A., Huyck M., Green R.C., Baldwin C.T., Farrer L.A. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Human Molecular Genetics 2006, 15:77-85.
15. He X.M., Zhang Z.X., Zhang J.W., Zhou Y.T., Tang M.N., Wu C.B., Hong Z. Paraoxonase 1 gene Gln192Arg polymorphism in and Alzheimer disease. Zhonghua Nei Ke Za Zhi 2006, 45:270-273.
16. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genetics 1993, 3:73-76.
17. Jarvik G.P., Rozek L.S., Brophy V.H., Hatsukami T.S., Richter R.J., Schellenberg G.D., Furlong C.E. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:2441-2447.
18. Klimkowicz-Mrowiec A., Marona M., Wolkow P., Witkowski A., Maruszak A., Styczynska M., Barcikowska M., Szczudlik A., Slowik A. Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the Polish population. Dementia and Geriatric Cognitive Disorders 2011, 31:417-423.
19. Kuo Y.M., Emmerling M.R., Bisgaier C.L., Essenburg A.D., Lampert H.C., Drumm D., Roher A.E. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochemical and Biophysical Research Communications 1998, 252:711-715.
20. Larson E.B., Kukull W.A., Katzman R.L. Cognitive impairment: dementia and Alzheimer's disease. Annual Review of Public Health 1992, 13:431-449.
21. Lehtimaki T., Lehtinen S., Solakivi T., Nikkila M., Jaakkola O., Jokela H., Yla-Herttuala S., Luoma J.S., Koivula T., Nikkari T. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19:23-27.
22. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters 1991, 286:152-154.
23. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959, 22:719-748.
24. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009, 62:1006-1012.
25. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
26. Paragh G., Balla P., Katona E., Seres I., Egerhazi A., Degrell I. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. European Archives of Psychiatry and Clinical Neuroscience 2002, 252:63-67.
27. Scacchi R., Gambina G., Martini M.C., Broggio E., Vilardo T., Corbo R.M. Different pattern of association of paraoxonase Gln192→Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease. Neuroscience Letters 2003, 339:17-20.
28. Shi J.J., Zhang S.Z., Ma C., Tang M.N., Liu X.H., Wang Y.C., Han H.Y., Guo Y.B., Feng R.M., Miao G.D. Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese. Di Yi Jun Yi Da Xue Xue Bao 2004, 24:371-374.
29. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 2010, 25:603-605.
30. Wehr H., Bednarska-Makaruk M., Graban A., Lipczynska-Lojkowska W., Rodo M., Bochynska A., Ryglewicz D. Paraoxonase activity and dementia. Journal of the Neurological Sciences 2009, 283:107-108.
31. Wilcock G.K., Ballard C.G., Cooper J.A., Loft H. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. Journal of Clinical Psychiatry 2008, 69:341-348.
32. Wingo T.S., Rosen A., Cutler D.J., Lah J.J., Levey A.I. Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases. Neurobiology of Aging 2012, 33:5.
33. Yamada M., Sodeyama N., Itoh Y., Otomo E., Matsushita M., Mizusawa H. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke: A Journal of Cerebral Circulation 2002, 33:896-900.
34. Zuliani G., Ble A., Zanca R., Munari M.R., Zurlo A., Vavalle C., Atti A.R., Fellin R. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurologica Scandinavica 2001, 103:304-308.